Aclaris Therapeutics Inc (ACRS) — Long-term Investment Intensity
Aclaris Therapeutics Inc (ACRS) has a Long-term Investment Intensity of 40.6% as of September 2025. Long-term investments of $71.30 Million represent 40.6% of total assets of $175.53 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ACRS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aclaris Therapeutics Inc Long-term Investment Intensity (2014–2024)
This chart shows how Aclaris Therapeutics Inc's Long-term Investment Intensity has evolved across 8 annual periods from 2014 to 2024. As of September 2025, the intensity stands at 40.6%, reflecting long-term investments of $71.30 Million against total assets of $175.53 Million USD. For the complete balance sheet picture, see Aclaris Therapeutics Inc (ACRS) total assets.
Annual Long-term Investment Intensity for Aclaris Therapeutics Inc (2014–2024)
The table below presents the year-by-year Long-term Investment Intensity for Aclaris Therapeutics Inc from 2014 to 2024, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Aclaris Therapeutics Inc for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 41.0% | $90.30 Million | $220.33 Million | ▲ +9.2 pp |
| 2023 | 31.8% | $62.77 Million | $197.41 Million | ▲ +27.0 pp |
| 2022 | 4.8% | $12.24 Million | $254.60 Million | ▼ -8.8 pp |
| 2021 | 13.6% | $34.24 Million | $251.21 Million | ▲ +7.5 pp |
| 2017 | 6.2% | $15.00 Million | $243.51 Million | ▼ -14.8 pp |
| 2016 | 21.0% | $36.91 Million | $176.09 Million | ▲ +13.3 pp |
| 2015 | 7.6% | $7.17 Million | $94.08 Million | ▲ +4.6 pp |
| 2014 | 3.0% | $518.00K | $17.38 Million | — |